Get it on Google Play

SELLAS to present Phase 2 SLS009 data at ASH meeting in December

November 4, 2026 9:01 AM EST Send to a Friend
SELLAS Life Sciences Group (NASDAQ: SLS) announced it will present Phase 2 clinical data for SLS009 (tambiciclib) at the 68th ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login